Listed

IGC Pharma, Inc.

IGCNYSECIK 1326205HealthcareFiscal year ends Dec 31

Reports and events: 271 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

IGC Pharma, Inc., Reports and events
FiledFormWhat it isAccession number
2022-09-0916:55 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001185185-22-001082
2022-08-0517:20 ET10-QQuarterly reportPeriod 2022-06-300001185185-22-000890
2022-07-2508:47 ETDEF 14AProxy statementPeriod 2022-09-090001185185-22-000846
2022-06-2317:50 ET10-KAnnual reportPeriod 2022-03-310001185185-22-000768
2022-06-0915:23 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-22-000734
2022-05-1216:49 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-22-000608
2022-04-1817:23 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-22-000461
2022-03-2316:31 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001185185-22-000312
2022-02-1016:06 ET10-QQuarterly reportPeriod 2021-12-310001185185-22-000162
2022-01-1816:55 ET8-K5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001185185-22-000067
2021-12-0210:01 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001185185-21-001785
2021-11-1917:17 ET8-K1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001185185-21-001711
2021-10-2916:20 ET10-QQuarterly reportPeriod 2021-09-300001185185-21-001552
2021-10-1516:46 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001185185-21-001484
2021-09-1517:14 ETDEF 14AProxy statementPeriod 2021-10-150001185185-21-001301
2021-08-1117:07 ET10-QQuarterly reportPeriod 2021-06-300001185185-21-001100
2021-06-1417:26 ET10-KAnnual reportPeriod 2021-03-310001185185-21-000802
2021-02-1617:58 ET10-QQuarterly reportPeriod 2020-12-310001185185-21-000201
2021-01-1417:48 ET8-K5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits0001185185-21-000081
2021-01-1317:04 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-21-000077
2020-12-2220:56 ET8-K8.01 Other events0001185185-20-001766
2020-12-0816:16 ETDEF 14AProxy statementPeriod 2021-01-110001185185-20-001724
2020-11-2016:06 ET10-QQuarterly reportPeriod 2020-09-300001185185-20-001659
2020-08-2014:59 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-20-001222
2020-08-1916:06 ET10-QQuarterly reportPeriod 2020-06-300001185185-20-001220
2020-08-1117:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-20-001126
2020-07-2019:08 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-20-001030
2020-07-1320:00 ET10-KAnnual reportPeriod 2020-03-310001185185-20-000984
2020-05-1316:04 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001185185-20-000623
2020-05-0821:34 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-20-000572
2020-03-2720:10 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-20-000356
2020-03-1618:35 ET8-K8.01 Other events0001185185-20-000298
2020-02-1016:06 ET10-QQuarterly reportPeriod 2019-12-310001185185-20-000150
2020-01-0916:05 ET8-K5.07 Shareholder vote results0001185185-20-000029
2019-12-1316:38 ETDEF 14AProxy statementPeriod 2020-01-070001185185-19-001718
2019-11-0617:53 ET10-QQuarterly reportPeriod 2019-09-300001185185-19-001517
2019-08-0921:29 ET10-QQuarterly reportPeriod 2019-06-300001185185-19-001094
2019-06-1417:19 ET10-KAnnual reportPeriod 2019-03-310001185185-19-000890
2019-03-2721:05 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-19-000412
2019-02-2608:37 ET8-K8.01 Other events0001185185-19-000283
2019-02-2220:18 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-19-000269
2019-02-1917:04 ET8-K3.03 Change to security holders’ rights; 9.01 Financial statements and exhibits0001185185-19-000263
2019-02-1220:44 ET10-QQuarterly reportPeriod 2018-12-310001185185-19-000224
2018-11-1318:25 ET8-K3.01 Delisting notice; 8.01 Other events0001185185-18-001968
2018-11-0219:16 ET8-K3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001185185-18-001897
2018-10-1620:21 ET10-QQuarterly reportPeriod 2018-09-300001185185-18-001848
2018-10-1019:45 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001185185-18-001826
2018-10-0117:15 ET8-K8.01 Other events0001185185-18-001782
2018-10-0106:09 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-18-001776
2018-09-2408:04 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001185185-18-001745

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 6, 2026, 16:27 ET. Listed shows no prices and gives no investment advice.